Histogen Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2022. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-06-03: Reporting owner Reyes Joyce; Form 3; Security Stock Option (right to buy); Transaction Holding.
- 2022-06-03: Reporting owner Reyes Joyce; Form 3; Security Stock Option (right to buy); Transaction Holding.
- 2022-06-01: Reporting owner Windham-Bannister Susan Richards; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-06-01: Reporting owner Satz Brian; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-06-03 holding as of filing | Reyes Joyce Officer (See Remarks) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.80 exercise price | 2022-06-03 | ||
| 2022-06-03 holding as of filing | Reyes Joyce Officer (See Remarks) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.80 exercise price | 2022-06-03 | ||
| 2022-06-01 | Windham-Bannister Susan Richards Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,000 1,000 owned after | $3.20 exercise price | 2022-06-03 | |
| 2022-06-01 | Satz Brian Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,000 1,000 owned after | $3.20 exercise price | 2022-06-03 | |
| 2022-06-01 | KISNER DANIEL L Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,000 1,000 owned after | $3.20 exercise price | 2022-06-03 | |
| 2022-06-01 | Jackson Jonathan Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,000 1,000 owned after | $3.20 exercise price | 2022-06-03 | |
| 2022-06-01 | Fuhrmann Rochelle Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,000 1,000 owned after | $3.20 exercise price | 2022-06-03 | |
| 2022-06-01 | Crean David Hugh Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,000 1,000 owned after | $3.20 exercise price | 2022-06-03 | |
| 2022-06-01 | Reyes Joyce Officer (See Remarks) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,833 7,833 owned after | $3.20 exercise price | 2022-06-03 | |
| 2022-02-24 | Mento Steven J Director, Officer (Interim President and CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +151,642 151,642 owned after | $0.24 exercise price | 2022-02-25 | |
| 2022-02-17 | Knudson Susan A. Officer (EVP, CFO & Corp Secy) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +169,800 169,800 owned after | $0.24 exercise price | 2022-02-22 | |
| 2022-02-17 | Latterich Martin Officer (SVP, Technical Operations) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +134,900 134,900 owned after | $0.24 exercise price | 2022-02-22 |